The clearance of Tryngolza gives Ionis its first wholly-owned, marketed medicine. Elsewhere, Robert Temple became the latest ...

Ionis Pharmaceuticals (IONS) announced that the U.S. Food and Drug Administration (FDA) has approved Tryngolza as an adjunct to diet to reduce ...

While the pharma is still developing a MorphoSys drug acquired in its $2.9 billion deal for the biotech, it is closing down sites in the U.S. and Germany.

Prodose Inc., which does business as Spirit Pharmaceuticals LLC, plans to close the local operation on Feb. 24, a state notice shows.

The global therapeutic drug monitoring market would expand at a compound annual growth rate (CAGR) of 8.4% from USD 2.30 billion in 2024 to ...

A new study assessing provincial and territorial variations in reimbursement criteria of drug coverage for patients covered by Canada's public pharmacare programs for two common cardiovascular ...

If you are interested in combining chemistry, biology, mathematics and computer techniques with pharmacology, physiology and biochemistry, to work on the development of treatments to prevent disease ...

The pharmaceutical industry in Saudi Arabia plays a pivotal role in the healthcare landscape of the Middle East and Africa (MEA). Driven by rising chronic disease rates and government investment ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

Hebei Wanbang Folon Pharmaceutical, has successfully had its drug registration application for Tao Hong Si Wu Granules accepted by the National Medical Products Administration. This innovative ...

SOUTH SAN FRANCISCO, Calif., Dec. 2, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer ...